BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND DDB2, Q92466, 1643, ENSG00000134574, FLJ34321 AND Treatment
14 results:

  • 1. Neurocognitive outcomes in adult survivors of neuroblastoma: A report from the Childhood Cancer Survivor Study.
    Hesko C; Liu W; Srivastava DK; Brinkman TM; Diller L; Gibson TM; Oeffinger KC; Leisenring WM; Howell R; Armstrong GT; Krull KR; Henderson TO
    Cancer; 2023 Sep; 129(18):2904-2914. PubMed ID: 37199722
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Association between obstructive sleep apnoea and cancer: a cross-sectional, population-based study of the DISCOVERY cohort.
    Palm A; Theorell-Haglöw J; Isakson J; Ljunggren M; Sundh J; Ekström MP; Grote L
    BMJ Open; 2023 Mar; 13(3):e064501. PubMed ID: 36868588
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Quantitative Proteomics Analysis Reveals Nuclear Perturbation in Human Glioma U87 cells treated with Temozolomide.
    Guo J; Yi GZ; Liu Z; Sun X; Yang R; Guo M; Li Y; Li K; Li K; Wang X; Song H; Qi S; Huang G; Liu Y
    Cell Biochem Funct; 2020 Mar; 38(2):185-194. PubMed ID: 31833081
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Half-life of alpha-fetoprotein in neonatal sacrococcygeal teratoma.
    Nam SH; Cho MJ; Kim DY; Kim SC
    J Pediatr Surg; 2018 Dec; 53(12):2470-2474. PubMed ID: 30249359
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Peripheral Blood Biomarkers Associated With Toxicity and treatment Characteristics After
    Campbell K; Karski EE; Olow A; Edmondson DA; Kohlgruber AC; Coleman M; Haas-Kogan DA; Matthay KK; DuBois SG
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):468-475. PubMed ID: 28871998
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The Risk Factors for Metastasis in Non-Ampullary Duodenal Neuroendocrine tumors Measuring 20 mm or Less in Diameter.
    Hatta W; Koike T; Iijima K; Asanuma K; Asano N; Musha H; Inomata Y; Sano T; Endo H; Ikehata A; Horii T; Ohyauchi M; Yokosawa S; Kasajima A; Fujishima F; Sasano H; Nakaya N; Nakamura T; Shimosegawa T
    Digestion; 2017; 95(3):201-209. PubMed ID: 28315861
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Repair of UVB-induced DNA damage is reduced in melanoma due to low XPC and global genome repair.
    Budden T; Davey RJ; Vilain RE; Ashton KA; Braye SG; Beveridge NJ; Bowden NA
    Oncotarget; 2016 Sep; 7(38):60940-60953. PubMed ID: 27487145
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Tinnitus following treatment for sporadic Acoustic neuroma.
    Overdevest JB; Pross SE; Cheung SW
    Laryngoscope; 2016 Jul; 126(7):1639-43. PubMed ID: 26403598
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. PD-L1 expression in small cell neuroendocrine carcinomas.
    Schultheis AM; Scheel AH; Ozretić L; George J; Thomas RK; Hagemann T; Zander T; Wolf J; Buettner R
    Eur J Cancer; 2015 Feb; 51(3):421-6. PubMed ID: 25582496
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Malignant melanoma cells acquire resistance to DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of ddb2/XPC-mediated DNA repair.
    Barckhausen C; Roos WP; Naumann SC; Kaina B
    Oncogene; 2014 Apr; 33(15):1964-74. PubMed ID: 23604128
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The efficacy of combination therapy using adeno-associated virus--interferon beta and trichostatin A in vitro and in a murine model of neuroblastoma.
    Hamner JB; Sims TL; Cutshaw A; Dickson PV; Rosati S; McGee M; Ng CY; Davidoff AM
    J Pediatr Surg; 2008 Jan; 43(1):177-82; discussion 182-3. PubMed ID: 18206478
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks.
    Batista LF; Roos WP; Christmann M; Menck CF; Kaina B
    Cancer Res; 2007 Dec; 67(24):11886-95. PubMed ID: 18089819
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Biochemical correlates of temozolomide sensitivity in pediatric solid tumor xenograft models.
    Middlemas DS; Stewart CF; Kirstein MN; Poquette C; Friedman HS; Houghton PJ; Brent TP
    Clin Cancer Res; 2000 Mar; 6(3):998-1007. PubMed ID: 10741727
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Brain derived neurotrophic factor protects human neuroblastoma cells from DNA damaging agents.
    Middlemas DS; Kihl BK; Moody NM
    J Neurooncol; 1999; 45(1):27-36. PubMed ID: 10728907
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.